Nephrology (blood purification) department

In May 2001, the blood purification room was established with 1 hemodialysis bed open. It belonged to the Department of Critical Care Medicine and admitted the first hemodialysis patient, You Xiaolian. In 2002, the first case of hemoperfusion-tandem hemodialysis was carried out to treat a patient with pesticide poisoning ( Main performer: Wu Sijun; Main equipment: Swedish Jinbao AK95 hemodialysis treatment device) In 2002, the first autologous arteriovenous fistula angioplasty was performed (main performers Ni Jianguo and Wu Sijun) In 2002, the first long-term deep vein surgery was performed Catheterization (mainly carried out by Wei Jingfeng and Wu Sijun) In November 2003, the first CRRT was carried out (mainly carried out by: Tang Weidong and Shao Weihong; main equipment: Swedish Jinbao Prisma multifunctional blood purification treatment device) In January 2004, The first plasma purification treatment for a patient with hyperbilirubinemia was carried out (main developers: Tang Weidong, Shao Weihong; main equipment: Swedish Jinbao Prisma multifunctional blood purification treatment device). In 2005, moved to No. 4, Guihua West Road, old hospital area 6 Building, the number of hemodialysis beds was expanded from 4 to 11, and the number of maintenance hemodialysis patients increased to more than 40. In 2005, the nephrology ward was established with 6 open beds. In 2008, the first case of great saphenous vein graft internal fistula angioplasty was performed. Surgery (main developers: Tu Yulan, Xu Jinhua) In 2010, it moved to the infusion room of the old hospital area at No. 4 Guihua West Road. The number of hemodialysis beds was expanded from 11 to 28, and the number of maintenance hemodialysis patients increased to 100 in 2013. In 2014, the first peritoneal dialysis catheter placement was performed (mainly performed by Wei Jingfeng and Shao Guomin), and the first peritoneal dialysis patient Zhu Renjuan was admitted. In November 2014, the first laparoscopic peritoneal dialysis catheter placement was performed ( Main developers: Vice President He Qiang and Shao Guomin of Zhejiang Provincial People's Hospital) In May 2015, with the overall relocation of the hospital, the Department of Nephrology is located in the east area on the 9th floor of the inpatient department, with 26 beds set up and open; the blood purification room is located in the inpatient department. In the east area on the first floor of the department, there are 51 hemodialysis beds, with 40 open beds starting from 47 at present.In July 2015, the first case of artificial liver treatment for a patient with drug-induced liver failure was carried out (main developers: Qi Ling and Shao Weihong; main equipment: Japan's Asahi Kasei multifunctional blood purification treatment device). In 2015, the first case of renal biopsy was carried out Surgery (Main developers: Xu Jinhua, Kong Xiangdong, Wang Yan) From 2014 to 2016, the first round of doctoral workstation in the Department of Nephrology was signed by Dr. He Qiang of Zhejiang Provincial People's Hospital. From 2016 to 2018, the second round of doctoral workstation in the Department of Nephrology was signed by Zhejiang Province Dr. Li Hua from Shaw Hospital Affiliated to the Medical University applied for the construction of key disciplines in Fuyang District from 2017 to 2019 (discipline leader: Wu Sijun). In September 2017, the first ultrasound-guided balloon dilatation (PTA) of arteriovenous fistula stenosis was performed. Surgery (main operators: Director Li Hua and Yu Xuhong of Shaw Hospital Affiliated to Zhejiang Medical University) In 2018, DSA-guided arteriovenous fistula stenosis balloon dilation (PTA) surgery was carried out (main operators: Xu Jinhua, Kong Xiangdong, Yu Xuhong) In July 2019, the first case of Seldinger peritoneal dialysis catheter placement was performed (mainly performed by: Dr. Liu Guangjun and Shao Guomin of the Nephrology Center of the First Affiliated Hospital of Zhejiang Medical University). In September 2019, the first case of severe hyperlipidemia was performed. Double plasma exchange (DFPP) treatment for patients with pancreatitis (main developers: Qi Ling, Shao Weihong) 2019-2021, the third round of doctoral workstation in the Department of Nephrology, contracted with Dr. Han Fei of the First Affiliated Hospital of Zhejiang Medical University 2021-2023, kidney The fourth round of doctoral workstation in internal medicine signed a contract with Dr. Han Fei from the First Affiliated Hospital of Zhejiang Medical UniversityIn 2017, he applied for the construction of key disciplines in Fuyang District (discipline leader: Wu Sijun). In September 2017, the first ultrasound-guided arteriovenous fistula stenosis balloon dilatation (PTA) was performed (main performer: Run Run Shao, affiliated with Zhejiang Medical University) Hospital Director Li Hua and Yu Xuhong) In 2018, DSA-guided arteriovenous fistula stenosis balloon dilatation (PTA) was performed (main performers: Xu Jinhua, Kong Xiangdong, Yu Xuhong) In July 2019, the first case of Seldinger peritoneal dialysis was performed Catheterization (mainly performed by: Drs. Liu Guangjun and Shao Guomin from the Nephrology Center of the First Affiliated Hospital of Zhejiang Medical University) In September 2019, the first double plasma exchange (DFPP) treatment was performed on a patient with severe pancreatitis with hyperlipidemia (mainly Developers: Qi Ling, Shao Weihong) 2019-2021, the third round of doctoral workstation in the Department of Nephrology, contracted with Dr. Han Fei of the First Affiliated Hospital of Zhejiang Medical University 2021-2023, the fourth round of doctoral workstation in the Department of Nephrology, signed with the Affiliated Hospital of Zhejiang Medical University Dr. Han Fei from the First HospitalIn 2017, he applied for the construction of key disciplines in Fuyang District (discipline leader: Wu Sijun). In September 2017, the first ultrasound-guided arteriovenous fistula stenosis balloon dilatation (PTA) was performed (main developer: Run Run Shao, affiliated with Zhejiang Medical University) Hospital Director Li Hua and Yu Xuhong) In 2018, DSA-guided arteriovenous fistula stenosis balloon dilatation (PTA) was performed (main performers: Xu Jinhua, Kong Xiangdong, Yu Xuhong) In July 2019, the first case of Seldinger peritoneal dialysis was performed Catheterization (mainly performed by: Drs. Liu Guangjun and Shao Guomin from the Nephrology Center of the First Affiliated Hospital of Zhejiang Medical University) In September 2019, the first double plasma exchange (DFPP) treatment was performed on a patient with severe pancreatitis with hyperlipidemia (mainly Developers: Qi Ling, Shao Weihong) 2019-2021, the third round of doctoral workstation in the Department of Nephrology, contracted with Dr. Han Fei of the First Affiliated Hospital of Zhejiang Medical University 2021-2023, the fourth round of doctoral workstation in the Department of Nephrology, signed with the Affiliated Hospital of Zhejiang Medical University Dr. Han Fei from the First Hospital

[Successively served as diagnosis and treatment team leader, director, and head nurse]

In 2001, Jin Zhicheng, director of the Department of Critical Care Medicine, and Sheng Ying, head nurse, led deputy chief physician Wu Sijun and nurse He Suying to establish Fuyang's first blood purification center. In February 2002, Tang Weidong, director of the Department of Critical Care Medicine, and Zhang Xiaonv, head nurse, led the medical staff of the blood purification center to further develop. In May 2004, Shao Weihong served as the deputy head nurse of the Critical Care Medicine (Hemodialysis) Department, mainly responsible for the nursing work of the blood purification center. In May 2006, Wu Sijun, director of the Renal (Blood Purification) Department, and Shao Weihong, head nurse of the Blood Purification Center, led the medical staff in the department to further improve the diagnosis and treatment specifications of the discipline and launched a series of new technology projects. The discipline has made great progress. It also assists Fuyang Second People's Hospital in training full-time blood purification nurses, so that the blood purification business can thrive in Fuyang District. In 2016, Chen Xiaorong was appointed as the deputy director of the Renal (blood purification) Department. In 2018, Xu Jinhua was appointed as the deputy director of the Renal (blood purification) Department. In 2020, Xu Jinhua was appointed as the director of the Renal (blood purification) Department.

【Current status of subject】

The Nephrology (Blood Purification) Department was established in May 2001. It is a key discipline in Fuyang District and the first medical unit to carry out hemodialysis in Fuyang District. Its comprehensive technical level ranks among the top in Hangzhou. The department has specialized outpatient clinics (including peritoneal dialysis clinics), nephrology wards, blood purification centers, etc. Among them, the blood purification center covers an area of more than 1,000 square meters, with 47 hemodialysis beds and an investment of more than 15,000 yuan in equipment; the renal ward has 26 open beds. The department currently has more than 50 medical staff, all of whom are qualified doctors (nurses), including 5 with medical master's degrees, and 10 directors and deputy chief doctors (nurses). It has a group of Chinese doctors and nurses who are brave in innovation and enterprising in the field of nephrology. Young experts are responsible for clinical, teaching and scientific research tasks in kidney diseases. Many of the medical staff in the department have won honorary titles such as 123 Outstanding Talents, "Top Ten" Nurses in Fuyang District, and Technical Experts.

【Diagnosis and treatment scope】

Routinely carry out integrated treatment of chronic kidney diseases, such as: acute and chronic glomerulonephritis, acute and chronic pyelonephritis, latent nephritis, Henoch-Schonlein purpura nephritis, diabetic nephropathy, hypertension and hypertensive nephropathy, nephrotic syndrome, acute and chronic renal function Failure, uremia, urinary tract infection, sequelae of mycoplasma and chlamydia infection, pregnancy-induced hypertension nephropathy, polycystic kidney disease, lupus nephropathy, hyperuricemia, uric acid nephropathy, gouty nephropathy, urinary tract stones, hereditary nephropathy, drug poisons and renal damage caused by various physical and chemical factors, as well as the integrated diagnosis and treatment of difficult and complicated renal diseases with traditional Chinese and Western medicine, and the key prevention and treatment of senile renal diseases. Through high-quality hemodialysis and integrated blood purification technology, personalized vascular access and specialized management of peritoneal dialysis, patients with end-stage renal disease can return to society.

【Technical Features】

The department is equipped with German RAL water treatment equipment, Swedish Jinbao hemodialysis treatment equipment, Swedish Jinbao hemodiafiltration treatment equipment, German Fresenius hemodialysis treatment equipment, German Fresenius hemodiafiltration treatment equipment, Japan Orient Hemodialysis treatment device, Toray hemodiafiltration treatment device from Japan, B. Braun hemodialysis treatment device from Germany, Livzon hemoperfusion treatment device from Zhuhai, Asahi Kasei multifunctional blood purification treatment device from Japan, fully automatic peritoneal dialysis machine, GE ultrasound from Germany machine, German Xeikon body composition analyzer, German Xeikon weight scale and other medical equipment. Routinely carry out various blood purification technologies, integrating continuous blood purification treatment, hemoperfusion, plasma exchange, immunoadsorption, bilirubin adsorption, artificial liver and other blood (plasma) purification and technology, peritoneal dialysis, colon dialysis technology; carry out percutaneous Arteriovenous intracavitary balloon dilatation, autologous internal fistuloplasty, transposition fistula angioplasty, great saphenous vein graft fistula angioplasty, internal fistula thrombectomy, deep vein catheterization and other vascular access establishment and Maintenance technology; carry out advanced technologies such as laparoscopic peritoneal dialysis catheterization and Seldinger peritoneal dialysis catheterization; use body composition analysis to carry out personalized nutrition treatment for dialysis patients and improve the nutritional status of dialysis patients.

【Scientific research results】

The department has 4 doctoral clinical research work stations. 13 provincial and municipal scientific research projects were initiated and completed, 4 of which were Zhejiang provincial projects (all completed), 9 projects were guided by Hangzhou Science and Technology Bureau and Fuyang District Science and Technology Bureau, and won 1 third-class district-level scientific and technological progress award. We applied to host 2 Hangzhou Municipal Continuing Education Training Classes and participated in 1 Zhejiang Provincial Continuing Education Training Class. Published 3 SCI academic papers and more than 50 academic papers in other national and provincial core medical journals.